Cell culturing technology Cellink has bought University of Freiburg's single-cell dispensing spinout Cytena for almost $34m.

Glovo, which counts several corporates as investors, has entered discussions with Uber and Deliveroo over a possible acquisition, while SoftBank could potentially provide equity funding.

Hillrom is paying $130m to snap up Johnson & Johnson-backed respiratory therapy system developer Breathe, which had raised at least $62m in funding.

SurveyMonkey has acquired the Campaign Monitor-owned online enterprise survey provider in a $68m deal that will give equity to Salesforce Ventures.

UW-founded cancer immunotherapy developer Neoleukin Therapeutics will merge with Aquinox in an all-share deal giving the spinout's shareholders roughly 38.6% equity in the new company.

Hewlett Packard Enterprise reportedly paid less than $50m for the assets of Qualcomm Ventures and CapitalG-backed MapR, which had once been valued at more than $1bn.

SoftBank Ventures Asia and Singtel Innov8 were among the investors in the $90m round, which closed alongside Carro’s acquisition of e-commerce marketplace Jualo.

Reliance Industries has acquired a majority stake in the fashion e-commerce platform through a $41.7m majority stake purchase that will enable Google to exit.

Alphabet and Celgene are among the investors facing a delayed exit from Rapt Therapeutics, which has postponed an initial public offering that would have raised up to $80m.

Quantum Signal has been bought by Ford after two decades of quietly producing technologies for robotic applications including autonomous driving.